Open for Enrollment Soon
This study will open for enrollment soon. Please contact the study team for more information and check back frequently.

DETECT LTFU ? Diagnosing Epilepsy To EffeCT change Long-Term Follow-Up - Clinical Trial

What is the Purpose of this Study?

Taking part in this study can last up to two years after joining. People will have a first visit and then follow up visits every six months, for up to five visits total. These visits may happen in person, by phone, or by video. At each visit, the study team will check overall health, seizures, medicines, hospital stays, and any problems with the implanted device. They will also review information collected by the Minder device and ask people to answer questions about mood, memory, anxiety, and quality of life. Between visits, the study doctor may review device information each month as part of regular care. Some people may be asked to come in for extra visits if needed. No new surgery is required because the device was already placed before the study.

What is the Condition Being Studied?

Epilepsy and Epilepsy Treatment Refractory

Who Can Participate in the Study?

People can join this study if they were part of an earlier study called DETECT and already had the Minder device placed in their body. They must have finished the DETECT study either by having an important seizure event or by completing the six month follow up visit. They must still have the Minder device implanted. They also must continue to meet the same health rules that were required for the DETECT study.

Age Group
Adults

What is Involved?

This study is being done to help doctors better understand and care for people with epilepsy whose seizures are hard to track with usual brain tests. Some people cannot use standard ways of watching seizures, so this study looks at how a device called the Minder System can help. The Minder System is already approved by the FDA and is not an experimental device. It helps collect information about seizures over time so doctors can make better treatment choices.

People who already took part in an earlier study and received the Minder device can join this study. The study will collect information about their general health, doctor visits, and how the information from the device helps with long term epilepsy care. Participants will continue seeing their regular doctor and will have checkups about every six months for up to two years after they received the device.

Study Details

Full Title
A prospective long-term follow-up study to evaluate the use of the Minder device to aid in treatment after actionable event identification in patients diagnosed with epilepsy.
Principal Investigator
Protocol Number
IRB: PRO00119101
NCT: NCT07110454
Phase
Phase N/A
ClinicalTrials.gov
Enrollment Status
Open for Enrollment Soon
Support Duke Health research or honor a loved one with a tribute gift.
Giving to Duke Health